These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27768593)

  • 1. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.
    Yacobovich S; Tuchinsky L; Kirby M; Kardash T; Agranyoni O; Nesher E; Redko B; Gellerman G; Tobi D; Gurova K; Koman I; Ashur Fabian O; Pinhasov A
    Oncotarget; 2016 Sep; 7(39):63549-63560. PubMed ID: 27556860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model.
    Levi B; Yacobovich S; Kirby M; Becker M; Agranyoni O; Redko B; Gellerman G; Pinhasov A; Koman I; Nesher E
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel dual-cyclic RGD peptides for α
    Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z
    Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
    Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
    Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic RGD and
    Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Activity Relationship of RGD-Containing Cyclic Octapeptide and αvβ3 Integrin Allows for Rapid Identification of a New Peptide Antagonist.
    Silva A; Xiao W; Wang Y; Wang W; Chang HW; Ames JB; Lam KS; Zhang Y
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α
    Koh B; Park SB; Yoon E; Yoo HM; Lee D; Heo JN; Ahn S
    J Pharm Sci; 2019 Nov; 108(11):3704-3712. PubMed ID: 31348936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new cyclic RGD peptide dimer for integrin αvβ3 imaging.
    Ma H; Hao P; Zhang L; Ma C; Yan P; Wang RF; Zhang CL
    Eur Rev Med Pharmacol Sci; 2016; 20(4):613-9. PubMed ID: 26957261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
    Chen X; Plasencia C; Hou Y; Neamati N
    J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel.
    Saraf P; Li X; Wrischnik L; Jasti B
    Pharm Res; 2015 Sep; 32(9):3087-101. PubMed ID: 26063045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
    Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
    Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation.
    Wu H; Jiang J; Xu H; Li Q; Cai J
    Expert Opin Ther Pat; 2016; 26(1):131-7. PubMed ID: 26560186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cilengitide-based cyclic RGD peptides as αvβ
    Meena CL; Singh D; Weinmüller M; Reichart F; Dangi A; Marelli UK; Zahler S; Sanjayan GJ
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127039. PubMed ID: 32094009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model.
    Karageorgis A; Claron M; Jugé R; Aspord C; Thoreau F; Leloup C; Kucharczak J; Plumas J; Henry M; Hurbin A; Verdié P; Martinez J; Subra G; Dumy P; Boturyn D; Aouacheria A; Coll JL
    Mol Ther; 2017 Feb; 25(2):534-546. PubMed ID: 28153100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
    Pilkington-Miksa M; Arosio D; Battistini L; Belvisi L; De Matteo M; Vasile F; Burreddu P; Carta P; Rassu G; Perego P; Carenini N; Zunino F; De Cesare M; Castiglioni V; Scanziani E; Scolastico C; Casiraghi G; Zanardi F; Manzoni L
    Bioconjug Chem; 2012 Aug; 23(8):1610-22. PubMed ID: 22770429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.